Inventor · disambiguated record
Pascal Chaux
Also filed as: CHAUX PASCAL
16 granted patents·3 pending applications·202 citations·filing 1997–2025
94Inventor score
Top patents by PatentIndex Score
19 records- 0188US7049413B2MAGE-A3 peptides presented by HLA class II moleculesLUDWIG INST CANCER RES·Filed 2001·Granted May 23, 2006·11 cites·19 claims
- 0286US6291430B1Mage-3 peptides presented by HLA class II moleculesLUDWIG INST CANCER RES·Filed 1998·Granted Sep 18, 2001·48 cites·15 claims
- 0385US5965535AMage-3 peptides presented by HLA class II moleculesLUDWIG INST CANCER RES·Filed 1997·Granted Oct 12, 1999·51 cites·11 claims
- 0483US6426217B1MAGE-3 peptides presented by HLA class II moleculesLUDWIG INST CANCER RES·Filed 2000·Granted Jul 30, 2002·17 cites·16 claims
- 0577US9504659B2Thermoreversible oil-in-water emulsionKLUCKER MARIE-FRANÇOISE·Filed 2007·Granted Nov 29, 2016·5 cites·3 claims
- 0677US7371845B2MAGE-A3 peptides presented by HLA class II moleculesLUDWIG INST CANCER RES·Filed 2006·Granted May 13, 2008·2 cites·20 claims
- 0776US7388072B2MAGE peptides presented by HLA class II moleculesLUDWIG INST CANCER RES·Filed 2003·Granted Jun 17, 2008·5 cites·21 claims
- 0875US6531451B1Tumor antigens and CTL clones isolated by a novel procedureLUDWIG INST CANCER RES·Filed 1999·Granted Mar 11, 2003·24 cites·2 claims
- 0972US2023277655A1Human Cytomegalovirus Immunogenic CompositionSANOFI PASTEUR·Filed 2022·Application pending·0 cites
- 1066US7351409B2Tumor antigens and CTL clones isolated by a novel procedureLUDWIG INST CANCER RES·Filed 2004·Granted Apr 1, 2008·3 cites·2 claims
- 1166US2009203124A1Mage-a3 peptides presented by hla-dr1 moleculesLUDWIG INST CANCER RES·Filed 2008·Application pending·0 cites
- 1265US11207403B2Human cytomegalovirus immunogenic compositionSANOFI PASTEUR·Filed 2020·Granted Dec 28, 2021·0 cites·13 claims
- 1364US11524069B2Human cytomegalovirus immunogenic compositionSANOFI PASTEUR·Filed 2018·Granted Dec 13, 2022·0 cites·20 claims
- 1464US6716809B1Mage-A3 peptides presented by HLA class moleculesLUDWIG INST CANCER RES·Filed 1999·Granted Apr 6, 2004·15 cites·14 claims
- 1564US2025228933A1Human Cytomegalovirus Immunogenic CompositionSANOFI PASTEUR·Filed 2025·Application pending·0 cites
- 1662US6369211B1MAGE-3 peptides presented by HLA class II moleculesLUDWIG INST CANCER RES·Filed 1999·Granted Apr 9, 2002·10 cites·17 claims
- 1760US7252825B2MAGE-3 peptides presented by HLA class II moleculesUNIV BRUXELLES·Filed 2002·Granted Aug 7, 2007·0 cites·13 claims
- 1848US6710172B1Tumor antigens and CTL clones isolated by a novel procedureLUDWIG INST CANCER RES·Filed 1999·Granted Mar 23, 2004·7 cites·1 claims
- 1943US7157091B1MAGE-A1 peptides presented by HLA class II moleculesLUDWIG INST CANCER RES·Filed 1999·Granted Jan 2, 2007·4 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Pascal Chaux files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →